Zogenix, Inc. (NASDAQ:ZGNX)

About the company

Zogenix, Inc. is a pharmaceutical company. It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

141

CEO

Stephen James Farr

Exchange

NASDAQ

Website

http://www.zogenix.com

$5.00M

Total Revenue

141

Employees

$1B

Market Capitalization

-2.99

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$5M

Operating Margin (in %)

Total operating margin

$-48M

Net Margin (in %)

Total net margin

$-12M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 12030.90 1376.00 5.13 18.97 43.06
Catalent, Inc. CTLT 10896.37 2872.00 5.47 104.47 3.63
Perrigo Co. Plc PRGO 7525.41 4837.00 1.29 51.34 3.02
Bausch Health Cos., Inc. BHC 6195.15 8597.00 8.65 -3.27 -21.96
Jazz Pharmaceuticals Plc JAZZ 6129.78 2188.00 2.12 22.40 12.81
United Therapeutics Corp. UTHR 5064.54 1443.00 1.76 9.77 36.59
MyoKardia, Inc. MYOK 4325.84 34.00 12.57 -13.95 -201.73
Axsome Therapeutics, Inc. AXSM 3004.40 None 20.39 -33.40 None
Pacira Biosciences, Inc. PCRX 2374.68 435.00 6.37 -5654.00 -0.02
SAGE Therapeutics, Inc. SAGE 2295.80 9.00 2.70 -3.55 -413.06
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
Corcept Therapeutics, Inc. CORT 2043.50 335.00 4.69 19.25 31.64
Prestige Consumer Healthcare, Inc. PBH 1862.52 963.00 1.57 13.14 14.77
Madrigal Pharmaceuticals, Inc. MDGL 1617.30 0.00 4.32 -15.83 -624.74
Revolution Medicines, Inc. RVMD 1581.20 48.00 4.10 -22.33 -146.29
Ironwood Pharmaceuticals, Inc. IRWD 1548.02 440.00 -21.91 18.26 19.14
Innoviva, Inc. INVA 1539.06 285.00 3.64 7.96 66.41
Intercept Pharmaceuticals, Inc. ICPT 1409.60 272.00 -41.95 -4.11 -127.53
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Supernus Pharmaceuticals, Inc. SUPN 1274.94 402.00 2.02 10.93 28.90
Zogenix, Inc. ZGNX 1272.60 5.00 3.47 -2.99 -241.62
Revance Therapeutics, Inc. RVNC 1230.46 0.00 4.86 -6.59 41.82
Theravance Biopharma, Inc. TBPH 1220.94 88.00 -8.57 -4.95 -280.80
Amphastar Pharmaceuticals, Inc. AMPH 1020.18 327.00 2.55 20.02 15.90
Endo International Plc ENDP 777.48 3014.00 -1.06 -2.77 -9.09
BellRing Brands, Inc. BRBR 745.68 954.00 -0.40 5.66 13.98
Assembly Biosciences, Inc. ASMB 680.34 16.00 3.05 -6.84 -601.75
Eagle Pharmaceuticals, Inc. EGRX 648.90 192.00 3.49 257.50 1.29
Aerie Pharmaceuticals, Inc. AERI 616.86 79.00 4.89 -3.05 -252.92
Collegium Pharmaceutical, Inc. COLL 582.76 299.00 4.17 -45.11 -4.21
Catalyst Pharmaceuticals, Inc. CPRX 536.07 119.00 5.22 12.22 36.09
Anika Therapeutics, Inc. ANIK 494.20 125.00 1.71 17.83 22.73
Intersect ENT, Inc. XENT 445.76 102.00 4.21 -8.93 -48.61
BioDelivery Sciences International, Inc. BDSI 392.84 130.00 5.62 -53.37 -5.01
ANI Pharmaceuticals, Inc. ANIP 367.56 203.00 1.88 -235.62 -0.67
Albireo Pharma, Inc. ALBO 331.24 11.00 3.37 -4.33 -730.55
MEI Pharma, Inc. MEIP 288.01 5.00 4.96 -7.38 -539.48
Mallinckrodt Plc MNK 199.08 3037.00 0.11 -0.17 -39.56
Agile Therapeutics, Inc. AGRX 161.66 None 2.63 -7.83 None
Marinus Pharmaceuticals, Inc. MRNS 151.20 0.00 5.85 -2.24 None
Cerecor, Inc. CERC 119.60 7.00 7.65 -5.31 -429.22
Ampio Pharmaceuticals, Inc. AMPE 98.38 1.00 68.80 -5.29 None
Evoke Pharma, Inc. EVOK 85.92 None 29.83 -12.79 None
AcelRx Pharmaceuticals, Inc. ACRX 85.60 2.00 -1.57 -1.53 -644.25
CTI BioPharma Corp. CTIC 83.78 3.00 3.74 -2.03 -111.83
Zynerba Pharmaceuticals, Inc. ZYNE 78.66 0.00 1.29 -2.19 -699.94
Aclaris Therapeutics, Inc. ACRS 73.80 4.00 1.29 -0.54 None
Adamas Pharmaceuticals, Inc. ADMS 70.84 57.00 -4.52 -0.76 -160.44
Oramed Pharmaceuticals, Inc. ORMP 61.02 3.00 4.91 -4.77 -464.15
Cassava Sciences, Inc. SAVA 56.62 41.00 2.98 -12.42 76.71
Cumberland Pharmaceuticals, Inc. CPIX 49.20 47.00 1.00 -10.93 -9.59
SCYNEXIS, Inc. SCYX 48.95 0.00 10.28 -1.26 -30.84
Natural Alternatives International, Inc. NAII 47.67 114.00 0.65 -12.61 -3.19
IsoRay, Inc. ISR 46.90 9.00 8.75 -14.00 -36.08
Lipocine, Inc. LPCN 39.90 0.00 9.50 -2.66 None
Acasti Pharma, Inc. ACST 35.84 827.00 2.33 -0.58 -7.45
Neos Therapeutics, Inc. NEOS 34.50 65.00 -2.65 -1.97 -26.74
PLx Pharma, Inc. PLXP 25.88 0.00 -2.48 -2.74 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 20.80 3.00 2.59 -1.76 -264.21
Regulus Therapeutics, Inc. RGLS 17.49 0.00 1.54 -0.82 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.65 8.00 0.67 -0.15 -798.18
Intec Pharma Ltd. NTEC 10.18 None 1.31 -0.24 None
Hepion Pharmaceuticals, Inc. HEPA 7.38 None 2.31 -0.62 None
VIVUS, Inc. VVUS 6.88 73.00 -0.15 -0.23 -39.28
Sonoma Pharmaceuticals, Inc. SNOA 6.35 19.00 1.01 -2.04 -25.58
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
Tonix Pharmaceuticals Holding Corp. TNXP 4.62 None 1.16 -0.10 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Zogenix's Long-Awaited Drug Approved With a Warning

4d ago, source: YAHOO!

Investors were likely wary that Fintepla was approved under the condition that its package insert carry a black box warning.

Zogenix: A Critical Launch

3d ago, source: Seeking Alpha

Just recently the FDA approved FINTEPLA for treatment of Dravet syndrome, a rare severe form of childhood epilepsy. Zogenix's ...

Zogenix (ZGNX) in Focus: Stock Moves 7.6% Higher

7d ago, source: Nasdaq

So make sure to keep an eye on this stock going forward, to see if this recent move higher can last. Zogenix currently has a ...

East Bay drug maker wins big FDA approval to treat kids with severe seizures

13d ago, source: The Business Journals

Kids with #DravetSyndrome can have 40 #seizures a day or more — now an East Bay company's newly approved drug could cut the ...

Zogenix Gets FDA Nod for Dravet Syndrome Seizure Treatment

13d ago, source: Nasdaq

Zogenix, Inc. ZGNX announced that the FDA has approved Fintepla (fenfluramine) oral solution, CIV for the treatment of ...

Zogenix shares slip despite FDA nod for Dravet syndrome drug

13d ago, source: BioWorld

While the FDA approved Zogenix Inc.’s Fintepla (fenfluramine), an oral treatment for patients ages 2 and older with seizures associated with Dravet syndrome, a rare, pediatric-onset form of epilepsy, ...

FDA Approves Fintepla for Seizures Associated with Dravet Syndrome

13d ago, source: PharmaLive

June 25, 2020 (GLOBE NEWSWIRE) — Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that the U.S. Food and Drug Administration (FDA) has ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.